Our Story
Our Labs
Oncology
Immunology
Pharmacokinetics
Libraries
Our News
Join Us
中文版
English
ES
pmglobal@precedo.cn
2026.03.06
Meet with our Team
AACR 2026 |April 17-22, 2026<br> San Diego Convention Center <br> Reach out to connect with a member of the PreceDo team at AACR26:
2025.08.01
Targeted Protein Degradation: From Ubiquitin to your Toolbox for VAV1 Degraders
Precedo Inc. provides in vitro biological evaluation of VAV1 degraders and in vivo assessment using autoimmune disease models, combined with DMPK studies to comprehensively evaluate their degradation properties and ADME characteristics.
2024.04.09
PreceDo Biobank at ISBER 2024
In April 2024, PreceDo attended the 25th International Society for Biological and Environmental Repositories (ISBER) Annual Meeting in Melbourne, Australia. Together with biobankers from over 30 countries, we engaged in discussions on the future direction of biobanking for the next 25 years. Among the key emerging trends, “Service Biobank” was identified as a major direction, and our Living Cancer Primary Cell Biobank and its translational platforms received strong recognition from attending experts.